Literature DB >> 3861621

Excess purine degradation in exercising muscles of patients with glycogen storage disease types V and VII.

I Mineo, N Kono, T Shimizu, N Hara, Y Yamada, S Sumi, K Nonaka, S Tarui.   

Abstract

To investigate purine catabolism in exercising muscles of patients with muscle glycogen storage disease, we performed ischemic forearm exercise tests and quantitated metabolites appearing in cubital venous blood. Two patients with glycogen storage disease type V and three with glycogen storage disease type VII participated in this study. Basal lactate concentrations lowered in every patient with glycogen storage disease type V or type VII. Two patients with glycogen storage disease type VII, who had markedly elevated concentrations of serum uric acid (14.3 and 11.9 mg/dl, respectively), showed high basal concentrations of ammonia (118 and 79 mumol/liter, respectively; 23 +/- 4 mumol/liter in healthy controls) and of hypoxanthine (23.4 and 20.4 mumol/liter, respectively; 2.0 +/- 0.4 mumol/liter in healthy controls). Other patients showed near normal measurements of these metabolites. After forearm exercise, ammonia, inosine, and hypoxanthine levels increased greatly in every patient studied, in contrast with the lack of increase in lactate levels. The incremental area under the concentration curves for venous ammonia was 13-fold greater in the glycogen storage disease group than in controls (1,120 +/- 182 vs. 83 +/- 26 mumol X min/liter). The incremental areas of inosine and hypoxanthine were also greater in the glycogen storage disease group (29.2 +/- 7.2 vs. 0.4 +/- 0.1 and 134.6 +/- 23.1 vs. 14.9 +/- 3.2 mumol X min/liter, respectively). The incremental areas of ammonia in controls and in glycogen storage disease patients strongly correlated with those of hypoxanthine (r = 0.984, n = 11, P less than 0.005). These findings indicated that excess purine degradation occurred in the exercising muscles of patients with glycogen storage disease types V and VII, and suggested that the ATP pool in the exercising muscles may be deranged because of defective glycogenolysis or glycolysis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3861621      PMCID: PMC423860          DOI: 10.1172/JCI112006

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

Authors:  S TARUI; G OKUNO; Y IKURA; T TANAKA; M SUDA; M NISHIKAWA
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

2.  Phosphofructokinase (PFK) deficiency due to a catalytically inactive mutant M-type subunit.

Authors:  A Zenella; M Mariani; G Meola; F Fagnani; G Sirchia
Journal:  Am J Hematol       Date:  1982-05       Impact factor: 10.047

3.  Increased ammonia production during forearm ischemic work test in McArdle's disease.

Authors:  K W Rumpf; H Wagner; H Kaiser; H M Meinck; H H Goebel; F Scheler
Journal:  Klin Wochenschr       Date:  1981-12-01

4.  Examination of a case of suspected McArdle's syndrome by 31P nuclear magnetic resonance.

Authors:  B D Ross; G K Radda; D G Gadian; G Rocker; M Esiri; J Falconer-Smith
Journal:  N Engl J Med       Date:  1981-05-28       Impact factor: 91.245

5.  Adenylate deaminase from rat muscle. Regulation by purine nucleotides and orthophosphate in the presence of 150 mM KCl.

Authors:  T J Wheeler; J M Lowenstein
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

6.  Exercise-induced changes in blood ammonia levels in humans.

Authors:  J E Wilkerson; D L Batterton; S M Horvath
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1977-12-22

7.  HPLC analysis of aromatic amino acids, nucleosides, and bases in plasma of acute lymphocytic leukemia on chemotherapy.

Authors:  M Zakaria; P R Brown; M P Farnes; B E Barker
Journal:  Clin Chim Acta       Date:  1982-11-24       Impact factor: 3.786

8.  Hereditary deficiency of lactate dehydrogenase M-subunit.

Authors:  T Kanno; K Sudo; I Takeuchi; S Kanda; N Honda; Y Nishimura; K Oyama
Journal:  Clin Chim Acta       Date:  1980-12-08       Impact factor: 3.786

9.  Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency.

Authors:  V H Patterson; K K Kaiser; M H Brooke
Journal:  Neurology       Date:  1983-06       Impact factor: 9.910

10.  Heterogeneity of the molecular lesions in inherited phosphofructokinase deficiency.

Authors:  S Vora; M Davidson; C Seaman; A F Miranda; N A Noble; K R Tanaka; E P Frenkel; S Dimauro
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

View more
  11 in total

1.  Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.

Authors:  Astrid Brull; Noemí de Luna; Albert Blanco-Grau; Alejandro Lucia; Miguel Angel Martin; Joaquin Arenas; Ramon Martí; Antoni L Andreu; Tomàs Pinós
Journal:  J Physiol       Date:  2015-05-18       Impact factor: 5.182

Review 2.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

3.  The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.

Authors:  Gisela Nogales-Gadea; Alfredo Santalla; Astrid Brull; Noemi de Luna; Alejandro Lucia; Tomàs Pinós
Journal:  J Inherit Metab Dis       Date:  2014-07-23       Impact factor: 4.982

Review 4.  Metabolic myopathies: functional evaluation by different exercise testing approaches.

Authors:  L Volpi; G Ricci; D Orsucci; R Alessi; F Bertolucci; S Piazza; C Simoncini; M Mancuso; G Siciliano
Journal:  Musculoskelet Surg       Date:  2011-03-04

5.  Muscle bio-energetics in acute glycolytic block: in vivo phosphorus-nuclear magnetic resonance study of iodo-acetate injected rats.

Authors:  Z Argov; D Nagle; U Giger; J S Leigh
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

Review 6.  Clinical and biochemical aspects of uric acid overproduction.

Authors:  J García Puig; F A Mateos
Journal:  Pharm World Sci       Date:  1994-04-15

7.  Contribution of creatine to protein homeostasis in athletes after endurance and sprint running.

Authors:  Fu-Chun Tang; Chun-Chen Chan; Po-Ling Kuo
Journal:  Eur J Nutr       Date:  2013-02-08       Impact factor: 5.614

8.  Unique Exercise Lactate Profile in Muscle Phosphofructokinase Deficiency (Tarui Disease); Difference Compared with McArdle Disease.

Authors:  Päivi Piirilä; Minna E Similä; Johanna Palmio; Tomi Wuorimaa; Emil Ylikallio; Satu Sandell; Petri Haapalahti; Lasse Uotila; Henna Tyynismaa; Bjarne Udd; Mari Auranen
Journal:  Front Neurol       Date:  2016-05-30       Impact factor: 4.003

9.  Higher oxidative stress in skeletal muscle of McArdle disease patients.

Authors:  Jan J Kaczor; Holly A Robertshaw; Mark A Tarnopolsky
Journal:  Mol Genet Metab Rep       Date:  2017-06-09

10.  McArdle Disease and Exercise Physiology.

Authors:  Yu Kitaoka
Journal:  Biology (Basel)       Date:  2014-02-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.